Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well chemotherapy based on positron emission tomography (PET)
scan works in treating patients with stage I or stage II Hodgkin lymphoma. Drugs used in
chemotherapy work in different ways to stop the growth of cancer cells, either by killing the
cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy)
may kill more cancer cells. Radiation therapy uses high energy x-rays to kill cancer cells.
Giving combination chemotherapy together with radiation therapy may kill more cancer cells
and allow doctors to save the part of the body where the cancer started. Comparing results of
diagnostic procedures, such as PET scan, done before, during, and after chemotherapy may help
doctors predict a patient's response to treatment and help plan the best treatment.